Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPM3480392 injection for postoperative moderate to severe abdominal pain (phase II)
CTR20222358Phase 2Completed
- Sponsor
- Luye Pharma Group
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of LPM3480392 in postoperative pain and breakthrough pain (2 arms), sponsored by Luye Pharma Group. Primary endpoint: SPID24. Started Sep 2022; status: completed.
02
Drugs
LPM3480392
03
Conditions
postoperative painbreakthrough pain
Beyond the preview
Go deeper on CTR20222358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222358.